Ticker
CLDXCompany Name
CELLDEX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -199.61M | $ -3.01 | 1 | 66.39M |
3/31/2025 | $ -178.85M | $ -2.69 | 1 | 66.38M |
12/31/2024 | $ -157.86M | $ -2.45 | 1 | 64.39M |
9/30/2024 | $ -154.08M | $ -2.32 | 1 | 66.29M |
6/30/2024 | $ -150.22M | $ -2.28 | 1 | 66.02M |
3/31/2024 | $ -144.88M | $ -2.46 | 1 | 58.87M |
12/31/2023 | $ -141.43M | $ -2.92 | 1 | 48.45M |
9/30/2023 | $ -124.61M | $ -2.64 | 1 | 47.26M |
6/30/2023 | $ -113.13M | $ -2.39 | 1 | 47.25M |
3/31/2023 | $ -118.64M | $ -2.51 | 1 | 47.21M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / (Shares WA * Share Factor)
(=) EBITPS
EBITPS for CELLDEX THERAPEUTICS INC is calculated as follows: EBIT [ $ -48.55M ] / (Shares WA [ 39.28M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -1.24 ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.79K |
---|---|
min | $ -9.71 |
max | $ 10.76 |
average | $ 1.16 |
median | $ 0.39 |
std | $ 3.41 |